Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Express Scripts
Mallinckrodt
McKesson
Colorcon

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Patent: 5,093,261

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 5,093,261
Title: Cancer-related antigen-specific human immunoglobulins and human/human hybridomas having the ability to produce said human immunoglobulins
Abstract:A new human/human fused cell clone derived from human B cells having the ability to produce immunoglobulins and human B cells substantially lacking the ability to produce immunoglobulins, antigen-specific human immunoglobulins produced by the human/human fused cell clone, and a method of producing the human immunoglobulins. More specifically, a human/human hybridoma having the ability to produce antigen-specific human immunoglobulins, which is a human/human fused cell strain derived from human B cells of a human patient with liver cancer and a subclone of a human lymphoblast cell strain; and antigen-specific human immunoglobulins produced by the human/human fused cell strain.
Inventor(s): Hagiwara; Hideaki (Kasai-shi, Hyogo-ken, JP), Nagao; Junzo (Kasai, JP)
Assignee: Hagiwara; Yoshihide (Kasai, JP) Hagiwara; Hideaki (Kasai, JP)
Application Number:07/196,610
Patent Claims:see list of patent claims

Details for Patent 5,093,261

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Csl Behring Ag CARIMUNE, CARIMUNE NF, PANGLOBULIN, SANDOGLOBULIN immune globulin intravenous (human) For Injection 102367 2000-07-27 ⤷  Try it Free 2009-03-03
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 2007-07-26 ⤷  Try it Free 2009-03-03
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 2009-10-02 ⤷  Try it Free 2009-03-03
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 2013-02-07 ⤷  Try it Free 2009-03-03
Bio Products Laboratory GAMMAPLEX immune globulin intravenous (human) Injection 125329 2009-09-17 ⤷  Try it Free 2009-03-03
Bio Products Laboratory GAMMAPLEX immune globulin intravenous (human) Injection 125329 2017-02-06 ⤷  Try it Free 2009-03-03
Csl Behring Ag HIZENTRA immune globulin subcutaneous (human), 20% liquid Injection 125350 2010-03-04 ⤷  Try it Free 2009-03-03
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Colorcon
Merck
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.